New horizons in platelets flow cytometry

被引:0
作者
Saboor, Muhammad [1 ]
Moinuddin, Moinuddin [1 ]
Ilyas, Samina [1 ]
机构
[1] Baqai Med Univ, Baqai Inst Hematol, Karachi 74600, Pakistan
来源
MALAYSIAN JOURNAL OF MEDICAL SCIENCES | 2013年 / 20卷 / 02期
关键词
flow cytometry; platelets; CD63; CD62;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Platelet flow cytometry is an emerging tool in diagnostic and therapeutic hematology. It is eminently suited to study the expression of platelet surface receptors both qualitatively as well as quantitatively. It can serve as a useful marker for the documentation of in vivo platelet activation, and thus, fore-warn the risk of thromboembolism in patients with diabetes mellitus, coronary syndromes, peripheral vascular diseases, and pre-eclampsia. This technique can also be extended to study and compare the effect of various antiplatelet drugs on the level of activation of platelets and to establish any dose-effect relationship of these drugs. Topographical localization of platelet granules and study of platelet-platelet and platelet-leukocyte interaction is also possible by this procedure. All these parameters serve as pointers towards the presence of activated platelets in the circulation with its thromboembolic consequences. This is a simple reliable and cost effective technique which has a wide application in the diagnosis of various inherited and acquired platelet disorders. Study of platelet cluster of differentiation (CD) markers in various inherited disorders i.e. Bernard Soulier's disease, von Willebrand disease, Glanzman's disease, and Grey platelet syndrome may help categories the molecular lesions in these oft under-studied disorders.
引用
收藏
页码:62 / 66
页数:5
相关论文
共 40 条
[11]   Influences of fixatives on flow cytometric measurements of platelet P-selectin expression and fibrinogen binding [J].
Hu, H ;
Daleskog, M ;
Li, NL .
THROMBOSIS RESEARCH, 2000, 100 (03) :161-166
[12]  
Huang KaoJean, 2005, Dengue Bulletin, V29, P142
[13]  
Lin CF, 2001, J MED VIROL, V63, P143, DOI 10.1002/1096-9071(20000201)63:2&lt
[14]  
143::AID-JMV1009&gt
[15]  
3.0.CO
[16]  
2-L
[17]   Application of flow cytometry to platelet disorders [J].
Linden, MD ;
Frelinger, AL ;
Barnard, MR ;
Przyklenk, K ;
Furman, MI ;
Michelson, AD .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2004, 30 (05) :501-511
[18]   Course of platelet activation markers after ischemic stroke [J].
Marquardt, L ;
Ruf, A ;
Mansmann, U ;
Winter, R ;
Schuler, M ;
Buggle, F ;
Mayer, H ;
Grau, AJ .
STROKE, 2002, 33 (11) :2570-2574
[19]   Platelet function tests and flow cytometry to monitor antiplatelet therapy [J].
Matzdorff, A .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2005, 31 (04) :393-399
[20]   Effect of glycoprotein IIb/IIIa inhibitors on CD62p expression, platelet aggregates, and microparticles in vitro [J].
Matzdorff, AC ;
Kühnel, G ;
Kemkes-Matthes, B ;
Pralle, H ;
Voss, R ;
Fareed, J .
JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 2000, 135 (03) :247-255